Compare LGVN & NEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGVN | NEON |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 27.5M |
| IPO Year | 2021 | 1994 |
| Metric | LGVN | NEON |
|---|---|---|
| Price | $0.81 | $1.80 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 370.0K | 97.8K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.76 | 37.88 |
| EPS | ★ N/A | N/A |
| Revenue | $709,000.00 | ★ $3,108,000.00 |
| Revenue This Year | N/A | $72.74 |
| Revenue Next Year | $10.81 | $28.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.48 | $1.27 |
| 52 Week High | $1.80 | $29.90 |
| Indicator | LGVN | NEON |
|---|---|---|
| Relative Strength Index (RSI) | 47.89 | 57.55 |
| Support Level | $0.74 | $1.66 |
| Resistance Level | $0.86 | $1.91 |
| Average True Range (ATR) | 0.06 | 0.11 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 62.76 | 67.14 |
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.